Evidence map›Paper›PMID 33094208›Full record

ArticleJournal of the Endocrine Society2020

Minimizing Glucose Excursions (GEM) With Continuous Glucose Monitoring in Type 2 Diabetes: A Randomized Clinical Trial.

Daniel J Cox, Tom Banton, Matthew Moncrief, Mark Conaway, Anne Diamond, Anthony L McCall

Erratum issued Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of the Endocrine Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT04632849 (The Use of Libre to Educate, Motivate and Activate Adults With Newly Diagnosed Type 2 Diabetes to Improve Metabolic Control and Reduce Their Reliance on Medication), which is not on this map. Cited by 36 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 5 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04632849 nacompletednot on this map

The Use of Libre to Educate, Motivate and Activate Adults With Newly Diagnosed Type 2 Diabetes to Improve Metabolic Control and Reduce Their Reliance on Medication: A Pilot Study

TypeinterventionalSponsorUniversity of VirginiaRan2020 to 2021Enrolled17ConditionsDiabetes Mellitus, Type 2ArmsGEM + CGM
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 5 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Observational
  20. The role of advanced technologies in improving diabetes outcomes.The American journal of managed care · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Daniel J CoxUniversity of Virginia School of Medicine, Center for Behavioral Medicine Research, Charlottesville, Virginia.ORCID 0000-0002-0910-5306
Tom BantonUniversity of Virginia School of Medicine, Center for Behavioral Medicine Research, Charlottesville, Virginia.
Matthew MoncriefUniversity of Virginia School of Medicine, Center for Behavioral Medicine Research, Charlottesville, Virginia.
Mark ConawayUniversity of Virginia School of Medicine, Public Health Sciences, Charlottesville, VA.
Anne DiamondUniversity of Virginia School of Medicine, Center for Behavioral Medicine Research, Charlottesville, Virginia.
Anthony L McCallUniversity of Virginia School of Medicine, Endocrinology and Metabolism, Charlottesville, VA.
University of Virginia · US

Funding

Treating Type 2 Diabetes by Reducing Postprandial Glucose Elevations: A Paradigm Shift in Lifestyle ModificationR01DK108957 · NIDDK · UNIVERSITY OF VIRGINIA · PI COX, DANIEL JOSEPH · 2016 to 2019
$2.7M
NIDDK NIH HHS R01 DK108957
6 · The paper itself

Abstract

This study aimed to compare conventional medication management of type 2 diabetes (T2D) to medication management in conjunction with a lifestyle intervention using continuous glucose monitoring to minimize glucose excursions. Thirty adults (63% female; mean age, 53.3 years) who were diagnosed with T2D for less than 11 years (mean, 5.6 years), had glycated A

Indexed as

continuous glucose monitoringexerciseglycemic loadphysical activitiespostprandial blood glucosetype 2 diabetes mellitus

Identifiers

PMID33094208
PMCPMC7566397
OpenAlexW3073688883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.